Use of granulocyte colony‐stimulating factor in the treatment of methimazole‐induced agranulocytosis: a case report

A comparison of this case to previously published reports suggests that granulocyte colony‐stimulating factor may be associated with improved prognosis in severe antithyroid drug‐induced neutropenia, and that weight‐based doses could be an appropriate strategy.

Detalles Bibliográficos
Autores principales: Birmingham, Asha, Mancuso, Carissa, Williams, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628249/
https://www.ncbi.nlm.nih.gov/pubmed/29026576
http://dx.doi.org/10.1002/ccr3.1124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628249/
https://www.ncbi.nlm.nih.gov/pubmed/29026576
http://dx.doi.org/10.1002/ccr3.1124

Ejemplares similares